MS Newbies: Recently Approved and Pipeline Drugs for the Treatment of Multiple Sclerosis Webcast

MS Newbies: Recently Approved and Pipeline Drugs for the Treatment of Multiple Sclerosis Webcast is organized by AchieveCE.

Release Date: 11/22/2021
Expiration Date: 09/29/2027

About this course:
The field of Multiple Sclerosis is ever-changing, with new targets and biomarkers being discovered each year. It can be challenging to stay up to date on newly approved agents given so many different components that play a role in treatment of Multiple Sclerosis. This activity will review the newest FDA-approved Multiple Sclerosis treatment agents including efficacy and safety features. This activity will also provide clinicians with drug/patient characteristics that are critical for appropriate treatment selection and recommendations.

What you’ll learn:
Pharmacist Learning Objectives
At the conclusion of this continuing education activity, the participant will be able to:

• Discuss the mechanism of action of newly approved MS treatments
• Discuss the mechanism of action of pipeline multiple sclerosis treatments
• Discuss literature to date for approval of new agents and pending trials for pipeline MS treatments

Nurse / Pharmacy Technician Learning Objectives
At the conclusion of this continuing education activity, the participant will be able to:

• Review the mechanism of action of newly approved MS treatments
• Review how pipeline multiple sclerosis treatments work
• Discuss literature to date for approval of new agents and pending trials for pipeline MS treatments